We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-2.45%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$10.1B
AUM Growth
-$4.47B
Cap. Flow
-$3.98B
Cap. Flow %
-39.35%
Top 10 Hldgs %
25.88%
Holding
2,114
New
677
Increased
359
Reduced
350
Closed
725

Top Buys

Rank Stock Value
1
AEE icon
Ameren
AEE
+$161M
2
ETR icon
Entergy
ETR
+$126M
3
DHR icon
Danaher
DHR
+$124M
4
COO icon
Cooper Companies
COO
+$65.6M
5
PPL
PPL Corp
PPL
+$61.3M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$419M
2
CMS icon
CMS Energy
CMS
+$170M
3
DUK icon
Duke Energy
DUK
+$164M
4
C icon
Citigroup
C
+$124M
5
CVX icon
Chevron
CVX
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 13.02%
2 Utilities 9.78%
3 Financials 9.29%
4 Technology 8.37%
5 Consumer Discretionary 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTK icon
976
CALL
Cytokinetics
CYTK
$10.7B
$804K 0.01%
+20,000
New +$919K
PFLT icon
977
PennantPark Floating Rate Capital
PFLT
$740M
$803K 0.01%
+71,800
New +$801K
AKR icon
978
Acadia Realty Trust
AKR
$2.93B
$800K 0.01%
+38,165
New +$864K
LUCK
979
Lucky Strike Entertainment
LUCK
$915M
$797K 0.01%
81,641
-22,700
-22% -$238K
ENFN
980
DELISTED
Enfusion, Inc.
ENFN
$796K 0.01%
71,425
+40,037
+128% +$443K
ASPN icon
981
Aspen Aerogels
ASPN
$416M
$795K 0.01%
+124,357
New +$1.2M
TRN icon
982
Trinity Industries
TRN
$2.37B
$793K 0.01%
+28,262
New +$947K
GNW icon
983
Genworth Financial
GNW
$3.74B
$792K 0.01%
111,748
-377,252
-77% -$2.62M
IONS icon
984
Ionis Pharmaceuticals
IONS
$10.3B
$792K 0.01%
+26,261
New +$860K
SWTX
985
DELISTED
SpringWorks Therapeutics
SWTX
$785K 0.01%
+17,785
New +$819K
HQY icon
986
HealthEquity
HQY
$8.81B
$780K 0.01%
+8,827
New +$905K
MMM icon
987
3M
MMM
$92.3B
$780K 0.01%
5,308
-36,320
-87% -$5.34M
WVE icon
988
Wave Life Sciences
WVE
$1.01B
$778K 0.01%
+96,268
New +$1.05M
TPB icon
989
Turning Point Brands
TPB
$1.67B
$777K 0.01%
13,078
-19,196
-59% -$1.19M
SAFE
990
Safehold
SAFE
$1.1B
$768K 0.01%
41,003
-105,283
-72% -$1.85M
BL icon
991
BlackLine
BL
$1.86B
$764K 0.01%
15,785
-11,118
-41% -$609K
SMG icon
992
ScottsMiracle-Gro
SMG
$3.53B
$761K 0.01%
13,864
-74,396
-84% -$4.81M
CLMT icon
993
Calumet Specialty Products
CLMT
$4.16B
$760K 0.01%
+59,941
New +$941K
GFI icon
994
Gold Fields
GFI
$42.3B
$760K 0.01%
34,397
-153,067
-82% -$2.8M
JANX icon
995
Janux Therapeutics
JANX
$1.14B
$755K 0.01%
+27,964
New +$1.05M
MLNK
996
DELISTED
MeridianLink
MLNK
$755K 0.01%
+40,728
New +$787K
AHRT
997
AH Realty Trust
AHRT
$502M
$754K 0.01%
100,453
+41,834
+71% +$380K
CYH icon
998
Community Health Systems
CYH
$424M
$754K 0.01%
+279,291
New +$870K
OSBC icon
999
Old Second Bancorp
OSBC
$1.29B
$754K 0.01%
+45,323
New +$811K
PSMT icon
1000
Pricesmart
PSMT
$5.4B
$752K 0.01%
8,560
-2,488
-23% -$222K

Similar funds

Michael Gelband's Q1 2025 Portfolio in Review

As of Q1 2025, Michael Gelband held 2,114 positions worth $10.1B, down 31% from $14.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Michael Gelband withdrew a net $3.98B in Q1 2025, closing 725 positions and reducing 350 holdings. Its most notable exit was CMS Energy, an estimated $170M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8% a quarter earlier, followed by Utilities and Financials.

Against the trend, Michael Gelband opened a new position in Ameren worth $168M.

  • Michael Gelband's largest Q1 2025 buy was Ameren: 1,668,398 shares worth $168M.
  • Michael Gelband added most to Danaher in Q1 2025, an estimated $124M increase.
  • Michael Gelband's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $419M.
  • Michael Gelband fully exited CMS Energy in Q1 2025, selling an estimated $170M.
  • Michael Gelband's ten largest holdings make up 26% of its $10.1B portfolio in Q1 2025.
  • Michael Gelband opened 677 new positions and closed 725 in Q1 2025.
  • Michael Gelband's portfolio value fell 31% quarter-over-quarter to $10.1B.

Based on ExodusPoint Capital Management's 13F filing for Q1 2025, filed 14 May 2025.